This CT Scan story illustrates the ripoff that is the healthcare industry in the United States of America as corporations pilfer citizens.
When Anne Soloviev, a retiree who lives in Washington, D.C., received a prescription to treat toenail fungus, she never thought to ask how much it cost.
Valeant increased the price of a life saving old out of patent drug from $27.46 to $880 and another from $26.20 to $1,790.11, an evil act.
There is a broad trend in which even small pharma is turning to high-priced TV to encourage the use of their products. It is not research but advertising.
Health care is a serious issue that no political party should take lightly. It is clear the GOP was never serious, and they are now paying the price.
Even though many early-stage cancers can now be cured, most of those with advanced cancer eventually die of their disease.
Eight pharmaceutical companies more than doubled their lobbying spending in the first three months of 2017 under Donald Trump regime.
The latest flashpoint in the ongoing debate over high drug prices is Emflaza, an $89,000-a-year drug that treats Duchenne muscular dystrophy.
When a patient goes to the best hospital, he or she usually hopes for a doctor who is knowledgeable and experienced; women physicians.
Hospitals are getting slammed by drug price hikes that often have nothing to do with improving patient health, a new report has found.